News Archive

Human Oncostatin M is Functionally Equivalent to Mouse LIF in Supporting Mouse ES Cell Pluripotency & Germline Competency 21 Jun 2010: In this application note R&D Systems demonstrate human OSM is able to maintain ES cell pluripotency in a similar manner to mouse LIF, including long-term maintenance of pluripotency and the ability to differentiate in vitro, the ability to activate STAT3, and germline transmission competency. The study suggests that OSM may be an additional factor that plays a role in early embryonic development and that it may be used as an alternative to LIF in mouse ES cell culture. R&D Systems, Inc.

Agilent Technologies Launches Bio-Inert LC to Characterize Large Biomolecules, New Biological Entities 18 Jun 2010: Agilent Technologies Inc. today introduced the 1260 Infinity bio-inert quaternary liquid chromatography (LC) system designed to characterize and confirm large biomolecules, especially new biological entities (NBEs) and therapeutic monoclonal antibodies. The system is based on the new Agilent 1260 Infinity LC system with quaternary pump module. Agilent Technologies

Bridge4Bio Teams with Instream Partners to Focus on Investment Advice 18 Jun 2010: Life sciences and biotechnology organizations needing to raise capital or quickly identify corporate partners or merger/acquisition candidates worldwide can now benefit from receiving sound, focused investment advice following a collaborative pact forged between Bridge4Bio, LLC and Instream Partners, a FINRA member and leading investment banking and advisory corporate financial group. Bridge4Bio, LLC

AnaSpec Introduces New SensoLyte uPA & tPA Assay Kits 17 Jun 2010: AnaSpec is pleased to introduce two plasminogen activator assay kits – the SensoLyte AFC Urokinase (uPA) Assay Kit and the SensoLyte AMC tPA Assay Kit. These kits, optimized for inhibitor screening, contain high-performance fluorogenic substrates which exhibit high reactivity and low background signal. AnaSpec Inc.

CO2 Incubator Sterilization method with 90ºC Moist Heat Decontamination 17 Jun 2010: In this application note, Esco validate the Swiftcon 90ºC moist heat decontamination cycle of the Celculture CO2 Incubator by performing decontamination tests on 5 bacterial suspension preparations, including Aspergillus niger and Bacillus subtilis. After decontamination, the microbial suspension discs were placed on tubes containing PBS which were assayed by culturing methods to quantitate Total Viable Count at each location. Esco Micro Pte Ltd

Super Resolution Pioneer to Open MICROSCIENCE 2010 16 Jun 2010: Dr Jennifer Lippincott-Schwartz (NIH, US) – a pioneer of super resolution imaging - will give the opening Plenary Lecture at MICROSCIENCE 2010 in London’s docklands on Tuesday 29th June 2010. Royal Microscopical Society

ATMI® Adds Ultra-Clean 2-D and 3-D Bioprocess Vessels to IntegrityTM Single-Use Product Line 15 Jun 2010: ATMI LifeScience today unveiled an important extension to its Integrity™ product line for the biopharmaceutical and biotechnology industries with the introduction of a new range of single-use bioprocess vessels (BPVs). The new vessels are available from ATMI LifeSciences in both 2-D and 3-D bag formats, and are manufactured using the company’s exclusive Integrity TK8 polymer film. ATMI LifeSciences

Eco Friendly Packaged Pipette Tips from Integra Viaflo 15 Jun 2010: INTEGRA Viaflo has introduced GREEN PACK™ - an environmentally friendly version of its GripTips™ pipette tips for use with its range of electronic pipettes. Using 100% recyclable materials imprinted with soy based inks the new GREEN PACK™ packaging houses five inserts of non-sterile GripTips™, but without the tip boxes. VIAFLO an INTEGRA company

TAP’s Automated Stem Cell Processing Suite Premiers on Stand 820 at ISSCR 15 Jun 2010: The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is delighted to announce that for the first time it will be showing its full range of stem cell processing automation, to facilitate the production of high quality stem cells, on Stand 820 at the International Society of Stem Cell Research (ISSCR) Conference. The Automation Partnership

Promega and Cellular Dynamics Partner to Validate Stem Cell-Based In Vitro Assays for Predicting Drug-Induced Cardiotoxicity 15 Jun 2010: Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that have previously remained undetected until late in the development process or after release of the drug to the general public. Cellular Dynamics International